Detail akcie Inogen online

Business Summary: Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Inogen Inc revenues increased 4% to $348.7M. Net loss decreased 37% to $22.7M. Revenues reflect Non-U.S. revenue segment increase of 18% to $138.8M. Lower net loss reflects respiratory products segment loss decrease of 29% to $30.2M. Basic Earnings per Share excluding Extraordinary Items increased from -$1.52 to -$0.86.